MNT daily newsletter - 10 May 2017

Dear S.C.T.C Customer,
Welcome to today's MNT newsletter, containing the most recent headlines from your chosen news categories.

Chat with MNT on Facebook Messenger

Get the latest MNT news in Facebook Messenger. Chat with us now!

Just send us a message from our Facebook page.

Alternatively, use this direct link to chat directly on Messenger.

Nutrition / Diet News
Plant-rich DASH diet linked to lower risk of gout
A plant-rich diet that lowers blood pressure and is recommended for lowering heart disease risk may also lower the risk of gout, a study suggests.
10 May 2017
Weight loss with insulin resistance: Diet tips and strategies
What is insulin resistance and what how might it link to weight? Can insulin resistance be reversed and what lifestyle changes may help?
10 May 2017
New findings may explain the advantages of polyunsaturated fat
Previous research has demonstrated that saturated fat is more fattening and less muscle building than polyunsaturated fats.
10 May 2017
ImmusanT reports data on novel celiac disease diagnostic approach
ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.
10 May 2017
Type 2 diabetes: What is the average age of onset?
In this article, we look at a variety of risk factors for type 2 diabetes, as well as how to reduce the risk and when to get tested.
10 May 2017
Caution: Energy drinks put individuals with genetic heart condition at risk
Caffeinated energy drinks can trigger serious cardiac events including cardiac arrest in individuals not known to have a specific heart disease of genetic origin.
10 May 2017

You are receiving this newsletter because you subscribed through your MNT account on Medical News Today. If you wish to alter any of your subscription details (name, email address etc) or chosen news categories, please log into your newsletter preferences page.

To unsubscribe from these newsletters immediately, please click here.

No comments:

Post a Comment